• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Biogen Investigacion FI

BIOINVS:SM

Acquired

Biogen Investigacion FI (BIOINVS:SM) was acquired by POP:SM


Company Profile

Biogen Investigacion FI an open-end fund incorporated in Spain. The Fund's objective is capital appreciation. The Fund invests in international equity securities that are engaged in the health and biotechnology sector, mainly in the OECD markets. Additionally, The Fund invests in derivative instruments.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
Advertisement
sec ||= nil